London, Mar 14 : A bioabsorbable, drug-eluting stent appears to be a safe and effective way of treating blocked coronary arteries, according to results from the open-label ABSORB study.
Two years after implanting of an investigational, everolimus coronary stent in patients, boffins recorded no cardiac deaths, target lesion revascularizations, or stent thromboses, reports The Lancet.